Retinal vein occlusion (RVO) is a common cause of vision impairment and blindness. In RVO, thrombosis in a retinal vein and reduction in blood flow leads to the development of retinal hypoxia. Retinal hypoxia stimulates vascular endothelial cell growth factor (VEGF) production, resulting in the formation of neovascularization and vision loss. Currently, non-invasive imaging modalities are not available to track and quantify the tissue-level hypoxia in living animals. In this study, a novel organic room-temperature phosphorescence nanoparticle (PNPs) was developed and characterized for identification of retinal hypoxia in real-time in living rabbits. The ability of PNPs for hypoxia imaging was examined in rabbits with laser-induced RVO models (n=3). The location of retinal hypoxia was imaged before and after the intravitreal administration of PNPs at a concentration of 2.5 mg/mL and an injection dose of 50 µL. Phosphorescence imaging was acquired at different time points over 7 days alo
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.